Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The colon: an overlooked site for therapeutics in dialysis patients.
Poesen R, Meijers B, Evenepoel P. Poesen R, et al. Semin Dial. 2013 May-Jun;26(3):323-32. doi: 10.1111/sdi.12082. Epub 2013 Mar 4. Semin Dial. 2013. PMID: 23458264 Review.
Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease.
Meijers B, Poesen R, Claes K, Dietrich R, Bammens B, Sprangers B, Naesens M, Storr M, Kuypers D, Evenepoel P. Meijers B, et al. Among authors: poesen r. Kidney Int. 2015 Jan;87(1):210-6. doi: 10.1038/ki.2014.197. Epub 2014 Jun 4. Kidney Int. 2015. PMID: 24897037
A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
Meijers B, Metalidis C, Vanhove T, Poesen R, Kuypers D, Evenepoel P. Meijers B, et al. Among authors: poesen r. Nephrol Dial Transplant. 2017 Apr 1;32(4):707-714. doi: 10.1093/ndt/gfw461. Nephrol Dial Transplant. 2017. PMID: 28407129 Clinical Trial.
Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.
Poesen R, Ramezani A, Claes K, Augustijns P, Kuypers D, Barrows IR, Muralidharan J, Evenepoel P, Meijers B, Raj DS. Poesen R, et al. Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1525-33. doi: 10.2215/CJN.03100315. Epub 2015 Jul 7. Clin J Am Soc Nephrol. 2015. PMID: 26153127 Free PMC article.
Heparin-coated dialyzer membranes: is non-inferiority good enough?
Meijers BK, Poesen R, Evenepoel P. Meijers BK, et al. Among authors: poesen r. Kidney Int. 2014 Dec;86(6):1084-6. doi: 10.1038/ki.2014.315. Kidney Int. 2014. PMID: 25427085
Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD.
Poesen R, Viaene L, Verbeke K, Claes K, Bammens B, Sprangers B, Naesens M, Vanrenterghem Y, Kuypers D, Evenepoel P, Meijers B. Poesen R, et al. Clin J Am Soc Nephrol. 2013 Sep;8(9):1508-14. doi: 10.2215/CJN.00300113. Epub 2013 Jun 27. Clin J Am Soc Nephrol. 2013. PMID: 23813557 Free PMC article. Clinical Trial.
Albumin is the main plasma binding protein for indoxyl sulfate and p-cresyl sulfate.
Viaene L, Annaert P, de Loor H, Poesen R, Evenepoel P, Meijers B. Viaene L, et al. Among authors: poesen r. Biopharm Drug Dispos. 2013 Apr;34(3):165-75. doi: 10.1002/bdd.1834. Epub 2013 Jan 24. Biopharm Drug Dispos. 2013. PMID: 23300093
Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease.
Poesen R, Viaene L, Verbeke K, Augustijns P, Bammens B, Claes K, Kuypers D, Evenepoel P, Meijers B. Poesen R, et al. BMC Nephrol. 2014 Jun 9;15:87. doi: 10.1186/1471-2369-15-87. BMC Nephrol. 2014. PMID: 24912660 Free PMC article. Clinical Trial.
The gut-kidney axis.
Evenepoel P, Poesen R, Meijers B. Evenepoel P, et al. Among authors: poesen r. Pediatr Nephrol. 2017 Nov;32(11):2005-2014. doi: 10.1007/s00467-016-3527-x. Epub 2016 Nov 15. Pediatr Nephrol. 2017. PMID: 27848096 Review.
A liquid chromatography - tandem mass spectrometry method to measure a selected panel of uremic retention solutes derived from endogenous and colonic microbial metabolism.
de Loor H, Poesen R, De Leger W, Dehaen W, Augustijns P, Evenepoel P, Meijers B. de Loor H, et al. Among authors: poesen r. Anal Chim Acta. 2016 Sep 14;936:149-56. doi: 10.1016/j.aca.2016.06.057. Epub 2016 Jul 2. Anal Chim Acta. 2016. PMID: 27566350
24 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback